Measurable residual disease testing by next generation sequencing is more accurate compared with multiparameter flow cytometry in adults with B-cell acute lymphoblastic leukemia.
Yan N, Wang ZL, Wang XJ, Gale RP, Zhou YL, Zhao MY, Wu LX, Liao MY, Yang J, Wang CY, Zhu JH, Jiang H, Jiang Q, Liu YR, Chang YJ, Xu LP, Zhang XH, Ma TH, Huang XJ, Ruan GR.
Yan N, et al. Among authors: liu yr.
Cancer Lett. 2024 Aug 28;598:217104. doi: 10.1016/j.canlet.2024.217104. Epub 2024 Jul 4.
Cancer Lett. 2024.
PMID: 38969163